Chris Blanchette

School of Data Science
Novo Nordisk
School of Data Science
Vice President, Clinical Development & Outcomes Research - Novo Nordisk

Education: Ph.D. in Pharmaceutical Health Services Research, University of Maryland

Courses Taught: Healthcare Data Analysis HCIP 6102, Business Intelligence in Healthcare HCIP 6396

Dr. Christopher M. Blanchette is an epidemiologist and health services researcher with expertise in health economics and outcomes research, health data analytics, and pharmaceutical use. He is currently the Senior Director for Real World Analytics at Novo Nordisk and a member of the Health Informatics and Analytics Industry Advisory Board. He holds adjunct faculty positions at the W.G. (Bill) Heffner VA Medical Center, Salisbury, NC as well as with the Department of Pharmaceutical Marketing at the Saint Joseph's University Erivan Haub School of Business and the Division of Pharmaceutical Outcomes & Policy at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. He has over a decade of experience in leading and managing epidemiology, clinical and health services research programs, teams and departments in the pharmaceutical industry and in management consulting. Dr. Blanchette is the Editor-in-Chief of Drugs in Context, and a member of the editorial board for the Journal of Medical Economics and Current Medical Research and Opinion. He serves in leadership positions for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is a peer reviewer for the Agency for Healthcare Research and Quality's (AHRQ) Health Information Technology Research study section and the Patient-Centered Outcomes Research Institute (PCORI). Dr. Blanchette is an Associate Graduate Faculty member for the School of Data Science at UNC Charlotte.